Migraine

Pediatric Migraine

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine.

      

A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. 

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine.

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

The main purpose of this study is to determine the safety and efficacy of the study drug,  galcanezumab, in children with less than 14 headaches per month for three months.

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. 

Pediatric Migraine

Recruiting

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

Search Match Terms:

Pediatric Migraine

Enter your postal code
to see sites near you

View Trial

Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Search Match Terms:

Pediatric Migraine

Enter your postal code
to see sites near you

View Trial

Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

Search Match Terms:

Pediatric Migraine

Enter your postal code
to see sites near you

View Trial

Recruiting

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

Search Match Terms:

Pediatric Migraine

Enter your postal code
to see sites near you

View Trial

Not the right fit? Sign up to receive updates on new trials.

Pediatric Migraine

Recruiting

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

Search Match Terms:

Pediatric Migraine

Enter your postal codeto see sites near you

View Trial

Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Search Match Terms:

Pediatric Migraine

Enter your postal codeto see sites near you

View Trial

Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

Search Match Terms:

Pediatric Migraine

Enter your postal codeto see sites near you

View Trial

Recruiting

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

Search Match Terms:

Pediatric Migraine

Enter your postal codeto see sites near you

View Trial

Not the right fit? Sign up to receive updates on new trials.

Enter your postal code
to see sites near you

Enter your postal code
to see sites near you

Enter your postal code
to see sites near you

Enter your postal code
to see sites near you